Association Between Circulating Levels of Sex Steroid Hormones and Barrett's Esophagus in Men: A Case-Control Analysis

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 4, 2015, Pages 673-682

  Cook, Michael B ^a   Wood, Shannon N ^a   Cash, Brooks D ^b   Young, Patrick ^b   Acosta, Ruben D ^b   Falk, Roni T ^a   Pfeiffer, Ruth M ^a   Hu, Nan ^a   Su, Hua ^a   Wang, Lemin ^a   Wang, Chaoyu ^a   Gherman, Barbara ^c   Giffen, Carol ^d   Dykes, Cathy ^b   Turcotte, Veronique ^e   Caron, Patrick ^e   Guillemette, Chantal ^e   Dawsey, Sanford M ^a   Abnet, Christian C ^a   Hyland, Paula L ^a   Taylor, Philip R ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c WESTAT   (United States)

^d IMS Inc   (United States)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

BEEDS; Cancer Risk; Esophageal Neoplasms; Gonadal Steroid Hormones; SHBG

Indexed keywords

3 ANDROSTANEDIOL 17 GLUCURONIDE; 3 ANDROSTANEDIOL 3 GLUCURONIDE; ANDROSTANOLONE; ANDROSTENEDIOL; ANDROSTENEDIONE; ANDROSTERONE; ANDROSTERONE GLUCURONIDE; ESTRADIOL; ESTRONE; ESTRONE SULFATE; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE; SEX HORMONE BINDING PROTEIN; TESTOSTERONE; UNCLASSIFIED DRUG; SEX HORMONE BINDING GLOBULIN;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BARRETT ESOPHAGUS; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD REGURGITATION; GASTROESOPHAGEAL SYMPTOM SCORE; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MIDDLE AGED; RACE; SCORING SYSTEM; SMOKING; AGED; BLOOD; FEMALE; PATHOLOGY;

ADULT; AGED; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; SEX HORMONE-BINDING GLOBULIN;

EID: 84925039008     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.08.027     Document Type: Article

References (60)

1. Cook M.B., Dawsey S.M., Freedman N.D., et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev 2009, 18:1174-1182.
2. Cook M.B., Wild C.P., Forman D. Asystematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol 2005, 162:1050-1061.
3. Cook M.B., Kamangar F., Whiteman D.C., et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. JNatl Cancer Inst 2010, 102:1344-1353.
4. Freedman N.D., Murray L.J., Kamangar F., et al. Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut 2011, 60:1029-1037.
5. Hoyo C., Cook M.B., Kamangar F., et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol 2012, 41:1706-1718.
6. Kubo A., Cook M.B., Shaheen N.J., et al. Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium. Gut 2013, 62:1684-1691.
7. Cook M.B., Shaheen N.J., Anderson L.A., et al. Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology 2012, 142:744-753.
8. Cook M.B., Corley D.A., Murray L.J., et al. Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON). PLoS One 2014, 9:e103508.
9. Rutegard M., Nordenstedt H., Lu Y., et al. Sex-specific exposure prevalence of established risk factors for oesophageal adenocarcinoma. Br J Cancer 2010, 103:735-740.
10. Bodelon C., Anderson G.L., Rossing M.A., et al. Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women. Cancer Prev Res (Phila) 2011, 4:840-850.
11. Cheng K.K., Sharp L., McKinney P.A., et al. Acase-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer 2000, 83:127-132.
12. Lindblad M., Rodriguez L.A., Lagergren J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control 2005, 16:285-294.
13. Lofdahl H.E., Lu Y., Lagergren J. Sex-specific risk factor profile in oesophageal adenocarcinoma. Br J Cancer 2008, 99:1506-1510.
14. Schmidt M., Naumann H., Weidler C., et al. Inflammation and sex hormone metabolism. Ann N Y Acad Sci 2006, 1069:236-246.
15. Maggio M., Basaria S., Ceda G.P., et al. The relationship between testosterone and molecular markers of inflammation in older men. JEndocrinol Invest 2005, 28:116-119.
16. Liao C.H., Li H.Y., Yu H.J., et al. Low serum sex hormone-binding globulin: marker of inflammation?. Clin Chim Acta 2012, 413:803-807.
17. Kupelian V., Chiu G.R., Araujo A.B., et al. Association of sex hormones and C-reactive protein levels in men. Clin Endocrinol (Oxf) 2010, 72:527-533.
18. Rashid F., Khan R.N., Iftikhar S.Y. Probing the link between oestrogen receptors and oesophageal cancer. World J Surg Oncol 2010, 8:9.
19. Yang H., Sukocheva O.A., Hussey D.J., et al. Estrogen, male dominance and esophageal adenocarcinoma: is there a link?. World J Gastroenterol 2012, 18:393-400.
20. Lagergren J., Nyren O. Do sex hormones play a role in the etiology of esophageal adenocarcinoma? A new hypothesis tested in a population-based cohort of prostate cancer patients. Cancer Epidemiol Biomarkers Prev 1998, 7:913-915.
21. Manterola C., Muñoz S., Grande L., et al. Initial validation of aquestionnaire for detecting gastroesophageal reflux disease in epidemiological settings. JClin Epidemiol 2002, 55:1041-1045.
22. Sodergard R., Backstrom T., Shanbhag V., et al. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. JSteroid Biochem 1982, 16:801-810.
23. Vermeulen A., Verdonck L., Kaufman J.M. Acritical evaluation of simple methods for the estimation of free testosterone in serum. JClin Endocrinol Metab 1999, 84:3666-3672.
24. Starka L., Pospisilova H., Hill M. Free testosterone and free dihydrotestosterone throughout the life span of men. JSteroid Biochem Mol Biol 2009, 116:118-120.
25. Chandanos E., Lagergren J. The mystery of male dominance in oesophageal cancer and the potential protective role of oestrogen. Eur J Cancer 2009, 45:3149-3155.
26. Cronin-Fenton D.P., Murray L.J., Whiteman D.C., et al. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer 2010, 46:2067-2076.
27. Rutegard M., Lagergren P., Nordenstedt H., et al. Oesophageal adenocarcinoma: the new epidemic in men?. Maturitas 2011, 69:244-248.
28. Awan A.K., Iftikhar S.Y., Morris T.M., et al. Androgen receptors may act in a paracrine manner to regulate oesophageal adenocarcinoma growth. Eur J Surg Oncol 2007, 33:561-568.
29. Cooper S.C., Trudgill N.J. Subjects with prostate cancer areless likely to develop esophageal cancer: analysis of SEER 9 registries database. Cancer Causes Control 2012, 23:819-825.
30. Cooper S.C., Croft S., Day R., et al. Patients with prostate cancer are less likely to develop oesophageal adenocarcinoma: could androgens have a role in the aetiology of oesophageal adenocarcinoma?. Cancer Causes Control 2009, 20:1363-1368.
31. Lu Y., Lagergren J. Reproductive factors and risk of oesophageal cancer, a population-based nested case-control study in Sweden. Br J Cancer 2012, 107:564-569.
32. Green J., Roddam A., Pirie K., et al. Reproductive factors and risk of oesophageal and gastric cancer in the Million Women Study cohort. Br J Cancer 2012, 106:210-216.
33. Freedman N.D., Lacey J.V., Hollenbeck A.R., et al. The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort. Cancer 2010, 116:1572-1581.
34. Lagergren J., Jansson C. Sex hormones and oesophageal adenocarcinoma: influence of childbearing?. Br J Cancer 2005, 93:859-861.
35. Lindblad M., Garcia Rodriguez L.A., Chandanos E., et al. Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer 2006, 94:136-141.
36. Engeland C.G., Sabzehei B., Marucha P.T. Sex hormones andmucosal wound healing. Brain Behav Immun 2009, 23:629-635.
37. Ashcroft G.S., Mills S.J. Androgen receptor-mediated inhibition of cutaneous wound healing. JClin Invest 2002, 110:615-624.
38. Gilliver S.C., Ruckshanthi J.P., Hardman M.J., et al. 5alpha-dihydrotestosterone (DHT) retards wound closure by inhibiting re-epithelialization. JPathol 2009, 217:73-82.
39. Pergola C., Dodt G., Rossi A., et al. ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma. Proc Natl Acad Sci U S A 2008, 105:19881-19886.
40. Schooling C.M. Androgen activity and markers of inflammation among men in NHANES III. Am J Human Biol 2013, 25:622-628.
41. Furman D., Hejblum B.P., Simon N., et al. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A 2014, 111:869-874.
42. Kimchi E.T., Posner M.C., Park J.O., et al. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res 2005, 65:3146-3154.
43. Hu N., Clifford R.J., Yang H.H., et al. Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma. BMC Genomics 2010, 11:576.
44. Close H., Mason J.M., Wilson D., et al. Hormone replacement therapy is associated with gastro-oesophageal reflux disease: a retrospective cohort study. BMC Gastroenterol 2012, 12:56.
45. Menon S., Prew S., Parkes G., et al. Do differences in female sex hormone levels contribute to gastro-oesophageal reflux disease?. Eur J Gastroenterol Hepatol 2013, 25:772-777.
46. Nordenstedt H., Younes M., El-Serag H.B. Expression of androgen receptors in Barrett esophagus. JClin Gastroenterol 2012, 46:251-252.
47. Tihan T., Harmon J.W., Wan X., et al. Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus. Anticancer Res 2001, 21:3107-3114.
48. Stairs D.B., Nakagawa H., Klein-Szanto A., et al. Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus. PLoS One 2008, 3:e3534.
49. Zuguchi M., Miki Y., Onodera Y., et al. Estrogen receptor alpha and beta in esophageal squamous cell carcinoma. Cancer Sci 2012, 103:1348-1355.
50. Nozoe T., Oyama T., Takenoyama M., et al. Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus. Clin Cancer Res 2007, 13:4046-4050.
51. Kalayarasan R., Ananthakrishnan N., Kate V., et al. Estrogen and progesterone receptors in esophageal carcinoma. Dis Esophagus 2008, 21:298-303.
52. Taylor A.H., Al-Azzawi F. Immunolocalisation of oestrogen receptor beta in human tissues. JMol Endocrinol 2000, 24:145-155.
53. Liu L., Chirala M., Younes M. Expression of estrogen receptor-beta isoforms in Barrett's metaplasia, dysplasia and esophageal adenocarcinoma. Anticancer Res 2004, 24:2919-2924.
54. Akgun H., Lechago J., Younes M. Estrogen receptor-beta isexpressed in Barrett's metaplasia and associated adenocarcinoma of the esophagus. Anticancer Res 2002, 22:1459-1461.
55. Tiffin N., Suvarna S.K., Trudgill N.J., et al. Sex hormone receptor immunohistochemistry staining in Barrett's oesophagus and adenocarcinoma. Histopathology 2003, 42:95-96.
56. di Pietro M., Lao-Sirieix P., Boyle S., et al. Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus. Proc Natl Acad Sci U S A 2012, 109:9077-9082.
57. Masaka T., Iijima K., Endo H., et al. Gender differences in oesophageal mucosal injury in a reflux oesophagitis model of rats. Gut 2013, 62:6-14.
58. Sukocheva O.A., Wee C., Ansar A., et al. Effect of estrogen on growth and apoptosis in esophageal adenocarcinoma cells. Dis Esophagus 2013, 26:628-635.
59. Kambhampati S., Rajewski R.A., Tanol M., et al. Asecond-generation 2-methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a mouse xenograft model. Mol Cancer Ther 2013, 12:255-263.
60. Knigge U., Dejgaard A., Wollesen F., et al. The acute and long term effect of the H2-receptor antagonists cimetidine and ranitidine on the pituitary-gonadal axis in men. Clin Endocrinol (Oxf) 1983, 18:307-313.